Evofem Biosciences, Inc. (EVFM)
OTCMKTS: EVFM · Delayed Price · USD
0.0141
-0.0008 (-5.17%)
May 31, 2024, 3:59 PM EDT - Market closed
Company Description
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health.
Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.
Evofem Biosciences, Inc. is headquartered in San Diego, California.
Evofem Biosciences, Inc.
Country | United States |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 37 |
CEO | Ms. Saundra Pelletier |
Contact Details
Address: 12400 High Bluff Drive, Suite 600 San Diego, California 92130 United States | |
Phone | (858) 550-1900 |
Website | evofem.com |
Stock Details
Ticker Symbol | EVFM |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001618835 |
CUSIP Number | 30048L104 |
ISIN Number | US30048L3024 |
Employer ID | 20-8527075 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Saundra Pelletier | Interim Chair, President and Chief Executive Officer |
Ivy Zhang | Chief Financial Officer and Secretary |
Amy Raskopf | Senior Vice President of Investor Relations |
Kathy Gallo-Doyle | Vice President of Sales |
Rachael Hildebrandt P.H.R. | Head of Human Resources |
Ellen Thomas | Chief of Staff |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 15, 2024 | 8-K | Current Report |
May 15, 2024 | 10-Q | Quarterly Report |
May 2, 2024 | 8-K | Current Report |
Mar 28, 2024 | 8-K | Current Report |
Mar 27, 2024 | 10-K | Annual Report |
Mar 27, 2024 | 8-K | Current Report |
Mar 6, 2024 | 8-K | Current Report |
Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
Feb 1, 2024 | 8-K | Current Report |
Jan 31, 2024 | 8-K | Current Report |